Disclosures for "Comparative Efficacy and Safety of GLP-1 Receptor Agonists vs SGLT2 Inhibitors on the Risk of Alzheimer's Disease and Related Dementia: A Systematic Review and Meta-analysis "
-
Dr. Teli has nothing to disclose.
-
Ms. Koppanatham has nothing to disclose.
-
Dr. Bhavsar has nothing to disclose.
-
Mr. Lajczak has nothing to disclose.